{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:46:00Z","timestamp":1777934760822,"version":"3.51.4"},"reference-count":23,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Pediatric cataract surgery requires mydriasis, typically achieved with eye drops. An intracameral mydriatic combining tropicamide 0.02%, phenylephrine 0.31%, and lidocaine 1% is established in adults, but not in children. We aimed to evaluate the safety profile of this intracameral mydriatic in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a prospective observational cohort study on 40 patients, aged 8 weeks to 17 years, undergoing cataract surgery under general anesthesia (GA) and receiving 1 intracameral injection (0.1 mL) of the mydriatic. Thirteen patients underwent immediate sequential bilateral cataract surgery with a second injection to the second eye. We evaluated the incidence of hemodynamic adverse effects and assessed systemic exposure by quantification of plasma concentrations of phenylephrine and tropicamide at 4 fixed time points during the procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The highest plasma concentrations of phenylephrine and tropicamide were detected in the youngest patients (age 8 weeks\u20131 year), with a significant increase from baseline (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.023, respectively). In patients aged 1\u20136 years, significant changes were observed only in the plasma concentration of phenylephrine (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). For patients aged 6\u201317 years, there was no significant rise in phenylephrine nor in tropicamide plasma concentration (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.194 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 1.000). No clinically important changes in hemodynamic parameters occurred in any age group. Sequential bilateral administration did not result in an increase in plasma concentrations, nor in an increase of hemodynamic adverse effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Intracameral mydriatic injection did not induce cardiovascular adverse events, and systemic exposure was minimal in this pediatric population undergoing cataract surgery under GA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10807683251359451","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:53:50Z","timestamp":1759856030000},"page":"430-437","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Systemic Exposure to Intracameral Tropicamide 0.02%, Phenylephrine 0.31%, and Lidocaine 1% in Pediatric Cataract Surgery"],"prefix":"10.1177","volume":"41","author":[{"given":"Hanne","family":"Herbots","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Antwerp University Hospital, Edegem, Belgium."},{"name":"University of Antwerp, Antwerp, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Van Os","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Antwerp University Hospital, Edegem, Belgium."},{"name":"Department of Translational Neurosciences, University of Antwerp, Antwerp, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Aerts","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Antwerp University Hospital, Edegem, Belgium."},{"name":"University of Antwerp, Antwerp, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Jos\u00e9","family":"Tassignon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Antwerp University Hospital, Edegem, Belgium."},{"name":"Department of Translational Neurosciences, University of Antwerp, Antwerp, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Covaci","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Toxicological Centre, University of Antwerp, Antwerp, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Dumitrascu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Toxicological Centre, University of Antwerp, Antwerp, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Saldien","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Antwerp University Hospital, Edegem, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"e_1_3_9_2_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0635"},{"key":"e_1_3_9_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19980217)75:5<497::AID-AJMG8>3.0.CO;2-K"},{"issue":"7","key":"e_1_3_9_4_2","first-page":"1444","article-title":"Measuring and interpreting the incidence of congenital ocular anomalies: Lessons from a national study of congenital cataract in the UK","volume":"42","author":"Rahi JS","year":"2001","unstructured":"Rahi JS, , Dezateux C, , British Congenital Cataract Interest Group. Measuring and interpreting the incidence of congenital ocular anomalies: Lessons from a national study of congenital cataract in the UK. Invest Ophthalmol Vis Sci, 2001; 42(7):1444\u20131448.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_9_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.06.024"},{"key":"e_1_3_9_6_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.1999.770520.x"},{"key":"e_1_3_9_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211006575"},{"key":"e_1_3_9_8_2","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_2628_23"},{"key":"e_1_3_9_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2024.08.013"},{"key":"e_1_3_9_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(03)00522-4"},{"key":"e_1_3_9_11_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S118409"},{"key":"e_1_3_9_12_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-197303000-00003"},{"key":"e_1_3_9_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2019-000448"},{"key":"e_1_3_9_14_2","doi-asserted-by":"publisher","DOI":"10.5772\/22328"},{"key":"e_1_3_9_15_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S189671"},{"key":"e_1_3_9_16_2","doi-asserted-by":"publisher","DOI":"10.3928\/0191-3913-19780301-14"},{"key":"e_1_3_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.06.002"},{"key":"e_1_3_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(85)90229-6"},{"key":"e_1_3_9_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307587"},{"key":"e_1_3_9_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-022-02501-4"},{"key":"e_1_3_9_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000542192"},{"key":"e_1_3_9_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000001599"},{"key":"e_1_3_9_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/pan.13168"},{"key":"e_1_3_9_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/pan.12329"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10807683251359451","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251359451","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251359451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:33:37Z","timestamp":1777689217000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/10807683251359451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1177\/10807683251359451"],"URL":"https:\/\/doi.org\/10.1177\/10807683251359451","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}